Neutra Corp. | Income Statement

Fiscal year is February-January. All values USD Thousands.
2014
2015
2016
2017
2018
2019
SG&A Expense
965.90
635.90
1,036.00
370.70
163.70
1,709.30
EBIT
965.90
635.90
1,036.00
370.70
163.70
1,709.30
Unusual Expense
-
110.00
5.00
-
-
-
Interest Expense
292.40
1,150.90
401.60
497.20
355.30
720.80
Pretax Income
1,258.30
1,896.80
1,442.60
867.90
519.00
2,429.50
Consolidated Net Income
1,258.30
1,896.80
1,442.60
867.90
519.00
2,429.50
Net Income
1,258.30
1,896.80
1,442.60
867.90
519.00
2,429.50
Net Income After Extraordinaries
1,258.30
1,896.80
1,442.60
867.90
519.00
2,429.50
Net Income Available to Common
1,258.30
1,896.80
1,442.60
867.90
519.00
2,429.50
EPS (Basic)
6.53
3.36
1.25
0.41
0.10
0.16
Basic Shares Outstanding
192.70
563.90
1,154.40
2,140.40
5,262.10
14,907
EPS (Diluted)
6.53
3.36
1.25
0.41
0.10
0.16
Diluted Shares Outstanding
192.70
563.90
1,154.40
2,140.40
5,262.10
14,907
EBITDA
965.90
635.90
1,036.00
370.70
163.70
1,709.30

About Neutra

View Profile
Address
54 Sugar Creek Center Boulevard
Sugar Land Texas 77478
United States
Employees -
Website http://www.neutracorp.com
Updated 07/08/2019
Neutra Corp. engages in the development and marketing of natural wellness solutions, including cannabis-related products. It intends to market and sell nutra-ceutical supplement products to health practitioners. The nutra-ceutical natural medicine is an alternative system that focuses on natural remedies and the body's vital ability to heal and maintain itself.